Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control

We report the results of using intraoperative Cesium-131 (Cs-131) brachytherapy for recurrent GBM in a population of patients who also received bevacizumab.

Source: Brachytherapy - August 31, 2020 Category: Cancer & Oncology Authors: A. Gabriella Wernicke, Shoshana Taube, Andrew W. Smith, Alex Herskovic, Bhupesh Parashar, Theodore H. Schwartz Tags: Intraoperative Radiation Source Type: research